Apollo Endosurgery, Inc.
APEN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $76,856 | $62,989 | $42,048 | $50,713 |
| % Growth | 22% | 49.8% | -17.1% | – |
| Cost of Goods Sold | $34,429 | $28,030 | $19,806 | $25,038 |
| Gross Profit | $42,427 | $34,959 | $22,242 | $25,675 |
| % Margin | 55.2% | 55.5% | 52.9% | 50.6% |
| R&D Expenses | $11,908 | $9,524 | $7,670 | $10,384 |
| G&A Expenses | $20,582 | $18,448 | $11,062 | $13,588 |
| SG&A Expenses | $56,591 | $42,759 | $28,417 | $42,318 |
| Sales & Mktg Exp. | $36,009 | $24,311 | $17,355 | $28,730 |
| Other Operating Expenses | $1,750 | $1,875 | $1,949 | $2,095 |
| Operating Expenses | $70,249 | $54,158 | $38,036 | $54,797 |
| Operating Income | -$27,822 | -$19,199 | -$15,794 | -$29,122 |
| % Margin | -36.2% | -30.5% | -37.6% | -57.4% |
| Other Income/Exp. Net | -$7,833 | -$5,327 | -$6,675 | $1,965 |
| Pre-Tax Income | -$39,255 | -$24,526 | -$22,469 | -$27,157 |
| Tax Expense | $584 | $156 | $142 | $275 |
| Net Income | -$39,839 | -$24,682 | -$22,611 | -$27,432 |
| % Margin | -51.8% | -39.2% | -53.8% | -54.1% |
| EPS | -0.98 | -0.82 | -0.99 | -1.27 |
| % Growth | -19.5% | 17.2% | 22% | – |
| EPS Diluted | -0.98 | -0.82 | -0.99 | -1.27 |
| Weighted Avg Shares Out | 40,650 | 30,243 | 22,756 | 21,542 |
| Weighted Avg Shares Out Dil | 40,650 | 30,243 | 22,756 | 21,542 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4,671 | $8,318 | $5,251 | $4,052 |
| Depreciation & Amortization | -$196 | $2,014 | $2,306 | $2,503 |
| EBITDA | -$31,422 | -$14,194 | -$11,881 | -$26,211 |
| % Margin | -40.9% | -22.5% | -28.3% | -51.7% |